IL-2 Plasmid Electroporation: From Preclinical Studies to Phase I Clinical Trial
关键词: plasmid electroporation来源: 互联网
Electroporation (EP)-assisted intralesional delivery of Interleukin-2 (IL-2) plasmid (pDNA) has the potential to increase the local concentration of the expressed cytokine for an extended time in the injected tumors while minimizing its systemic concentration, in comparison with systemic delivery of the recombinant cytokine. Nonclinical Investigational New Drug application-enabling studies were performed in mice to evaluate the effect of intratumoral administration of murine IL-2 pDNA on local expression and systemic distribution of IL-2 transgene as well as the inhibition of established tumor growth. The safety of repeated administrations of a human IL-2 pDNA product candidate with EP was evaluated in rats. Following the nonclinical safety and efficacy studies, a human IL-2 pDNA product candidate intralesionally administered with EP to metastatic melanoma patients is currently being investigated in a phase I clinical trial.
推荐方法
- 李善兰
- 鞘 vagina vaginula
- Extractive Bioconversion in Aqueous Two-Phase Systems
- Cultivation of Mammalian Cells in Fixed-Bed Reactors
- β-半乳糖苷酶 β-galactosidase
- 蛋白质
- Interpretation of Genomic Copy Number Variants Using DECIPHER
- Expression Cloning of Neural Genes Using Xenopus laevis Oocytes
- 传染病防制与监测
- 格里马迪人 Grimaldi man